Publication | Closed Access

Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graft-versus-host disease

UrologyTransplantationKidney TransplantRenal InsufficiencyMedicineKidney TransplantationTransplantation-associated MicroangiopathyPharmacotherapyTransplant ArteriopathyChronic Kidney DiseaseCalcineurin InhibitorsNephrologyGraft Rejection